There has been some progress in the development of NLRP3 inhibitors some include: dapansutrile, and diarylsulfonylurea MCC-950.
Inflammasome
Lectin pathway
Immunophilins
Preceptor
Fc receptor
Bioptome
Transfersome
STAT protein